Michael E. Hart
Direttore/Membro del Consiglio presso Affygility Solutions
Posizioni attive di Michael E. Hart
Società | Posizione | Inizio | Fine |
---|---|---|---|
Affygility Solutions
Affygility Solutions Miscellaneous Commercial ServicesCommercial Services Affygility Solutions is a private company that provides occupational health, safety, and toxicology services to the life science industry. The company is based in Broomfield, CO and was founded in 2002. The company's services include the Affytrac EH&S management tool, potent compound safety and categorization, occupational exposure limits, and acceptable daily exposure limits for active pharmaceutical ingredients, and genotoxic impurity evaluations. The company has provided these services to small, mid-size, and large life science companies in over 65 different countries. The CEO is Dean Calhoun. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Michael E. Hart
Precedenti posizioni note di Michael E. Hart
Società | Posizione | Inizio | Fine |
---|---|---|---|
Allos Therapeutics, Inc.
Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Allos Therapeutics, Inc. is a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics. It focuses on the development and commercialization FOLOTYN a pralatrexate injection. FOLOTYN is a folate analogue metabolic inhibitor designed to accumulate preferentially in cancer cells. It targets the inhibition of dihydrofolate reductase, or DHFR, an enzyme critical in the folate pathway, thereby interfering with DNA and RNA synthesis and triggering cancer cell death. Allos Therapeutics is also developing FOLOTYN in other hematologic malignancies and solid tumors. The company was founded on September 1, 1992 and is headquartered in Westminster, CO. | Amministratore Delegato | 01/12/2001 | 09/03/2006 |
Direttore Finanziario/CFO | 01/12/2001 | 09/03/2006 | |
Presidente | 01/12/2001 | 09/03/2006 |
Formazione di Michael E. Hart
California State University-Fresno | Masters Business Admin |
University of California, Santa Barbara | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 5 |
Posizioni
Chief Executive Officer | 1 |
Director of Finance/CFO | 1 |
President | 1 |
Settori
Consumer Services | 3 |
Health Technology | 2 |
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 2 |
---|---|
Allos Therapeutics, Inc.
Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Allos Therapeutics, Inc. is a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics. It focuses on the development and commercialization FOLOTYN a pralatrexate injection. FOLOTYN is a folate analogue metabolic inhibitor designed to accumulate preferentially in cancer cells. It targets the inhibition of dihydrofolate reductase, or DHFR, an enzyme critical in the folate pathway, thereby interfering with DNA and RNA synthesis and triggering cancer cell death. Allos Therapeutics is also developing FOLOTYN in other hematologic malignancies and solid tumors. The company was founded on September 1, 1992 and is headquartered in Westminster, CO. | Health Technology |
Affygility Solutions
Affygility Solutions Miscellaneous Commercial ServicesCommercial Services Affygility Solutions is a private company that provides occupational health, safety, and toxicology services to the life science industry. The company is based in Broomfield, CO and was founded in 2002. The company's services include the Affytrac EH&S management tool, potent compound safety and categorization, occupational exposure limits, and acceptable daily exposure limits for active pharmaceutical ingredients, and genotoxic impurity evaluations. The company has provided these services to small, mid-size, and large life science companies in over 65 different countries. The CEO is Dean Calhoun. | Commercial Services |
- Borsa valori
- Insiders
- Michael E. Hart
- Esperienza